Designed to expand to every demand, GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) offers proven procedural success and long-term outcomes through flexibility, strength, and accuracy to treat iliac occlusive disease.
- 100% restoration of lumen diameter*
- 100% maintenance of stent length*
- 100% stent delivery at target site with no stent dislodgement*
- 96.9% primary patency*
≤ 30% residual stenosis due to high radial strength, even in highly calcified and non-compliant lesions*
Median length change was 0 mm, pre-deployed to final implant in the U.S. IDE study.*
All devices successfully delivered to and deployed at target site with no stent dislodgement, including 18% that were contralateral deliveries*
In TASC II C & D lesions 95.3% primary patency*
VBX Stent Graft brings advanced technology and a unique design to help you treat a range of challenging anatomies.
* Data on file. Based on nine month results from the Gore VBX FLEX IDE Clinical Study (N = 134 subjects) and follow-ups conducted for U.S. FDA approval.